1Webb MS, Logan P, Kanter PM, et al. Bally preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer. Cancer Chemother Pharmacol, 1998, 42(6):461.
2Mezei M, Gulasekharam V. Liposomes- a selective drug delivery system for the topical route of administration: I Lotion dosage form Life Sci, 1980, 26:473.
3Touitou E, Jungingex HE, Weiner ND, et al. Liposomes as carriers for topical and transdermal delivery. J Pharm Sci, 1994, 83(9):1189.
4Akamo Y, Mizuno I, Yotsuyanagil T, et al. Chemotherapy targeting regional lymph node by gastric submucosal injection of liposomal adriamycin in patients with gastric carcinoma. JPN J Cancer Res, 1994, 85(6) :652.
5Park JW, Hong K, Kirpolin DB, et al. Anti - HER2 immunoliposomes: enhanced efficacy attributable to targeted delivery. Clin Cancer Res, 2002, 8(4) : 1172.
6Tseng YL, Hong RL, Tao MH, et al. Sterically stabilized anti - idiotype immunoliposomes improve the therapeutic efficacy of doxorubicin in a murine B- cell lymphoma model. Int J Cancer, 1999, 80(5) :723.
7Gijsens A, Derycke A, Missiaen L, et al. Targeting of the photocytotoxic compound AIPcS4 to hela cells by transferrin conjugated peg - liposoms. Int J Cancer, 2002,101(1):78.
8Ni S, Stephenson SM, Lee RJ. Folate receptor targeted delivery of liposomal daunorubicin into tumor cells. Anticancer Res, 2002, 22(4):2131.
9Kono K, Nakai R, Morimoto K, et al. Temperature- dependent irderaction of thermo- sensitive polymer- modified liposomes with CV1 cells. FEBS Lett, 1999, 456(2):306.
10Hayashi H, Kono K, Takagishi T. Temperature- controlled release property of phospholipid vesides bearing a thermo - sensitive polymer, Biochim Biophys Acta, 1996, 1280(1):127.
2Harvey A.J., Speksnijder G., and Baugh L.R., 2002, Expression of exogenous protein in the egg white of transgenic chickens, Nature Biotechnology, 20:396-399.
3Kopchick J.J., Mills E., Rosenblum C., Taylor J., Macken F., Leung F., Smith J., and Chen H., 1991, Methods for the introduction of recombinant DNA into chicken embryos, Biotechnology, 16:275-293.
4Kwon M.S., Koo B.C., Choi B.R., Lee H.T., Kim Y.H., Ryu W. S., Shim H., Kim J.H., Kim N.H., and Kim T., 2004,Development of transgenic chickens expressing enhanced green fluorescent protein, Biochemical and Biophysical Research Communications, 320:442,--448.
5Lillico S.G, Sherman A., McGrew M.J., Robertson C.D., Smith J., Haslam C., Barnard P., Radcliffe P.A., Mitrophanous K. A. , Elliot E.A., and Sang H.M., 2007, Oviduct-specific expression of two therapeutic proteins in transgenic hens, Proceedings of the National Academy of Sciences, 104(6): 1771-1776.
6马仲华,主编,2004,家畜组织胚胎学,中国农业出版社,中国,北京,pp.311-321.
7Maeda T., Yamakawa Y., Masuda K., and Terada T., 1997, Distribution of blastodermal cells transferred to chick embryos for chimera production using windowed eggs, British Poultry Science, 38: 241-244.
8Mozdziak P.E., Borwompinyo S., and McCoy D.W., 2003, Development of transgenic chickens expressing bacterial betagalactosidase, Developmental Dynamics, 226:439-445.
9Sang H., and Perry M.M., 1989, Episomal replication of cloned DNA injected into the fertilized ovum of the hen, Gallus domesticus, Molecular Deproduction and Development, 1 (2): 98-106.
10Shuman R., and Shoffner R.N., 1982, Potential genetic modifications in the chicken (A): Proceedings of the 2nd world congress on genetic applied to livestock product ion, Madrid: The Organizing Cornmittee,Vl: 157-163.
